期刊文献+

三维适形放疗同期联合GP方案治疗晚期非小细胞肺癌临床分析 被引量:3

Clinical analysis of three dimensional conformal radiotherapy combined synchronous GP regimen in the treatment of locally advanced non small cell lung cancer
下载PDF
导出
摘要 目的评价三维适形放疗同期联合同步GP方案治疗局部晚期非小细胞肺癌的疗效及毒副反应。方法对资料完整的168例晚期非小细胞肺癌患者进行回顾性研究,其中单纯放疗83例,同步放化疗85例。放疗采用直线加速器6MV、15MV X线,剂量60~66gy/33次/7周。化疗采用吉西他滨(益非)+顺铂,在放疗第一周和第四周进行。结果随访3年。单纯放疗组1、3年生存率分别为62.7%和30.1%,放化疗组1、3年生存率分别为80%和40.7%。两组有显著差异P<0.01。结论晚期非小细胞肺癌同步放化疗可以提高局部控制率、提高生存率。两组毒副作用无显著差异。 Objective To evaluate the three dimensional conformal radiotherapy combined synchronous GP scheme treatment from locally advanced non-small cell lung cancer effect and side-effect.Methods Data of the whole 168 patients with terminal NSCLC were retrospected,of which only 83 cases got radiation therapy,the chemoradiation was 85 cases.Radiation therapy USES the straight line accelerator 6 MV,15 MV X-ray,dose 60-66 gy / 33 times / 7 weeks.Chemotherapy using gemcitabine plus cisplatin,in the first week and around the radiotherapy.Results By 3 years of follow-up,survival rates of pure radiation therapy group were 62.7% and 30.1% respectively,radiation and chemotherapy group were 80% and 40.7% respectively.Two groups were significantly different P0.01.Conclusions Advanced non-small-cell lung cancer chemoradiation can improve local control,improve survival.Side effects in two groups have no significant differences.
出处 《齐齐哈尔医学院学报》 2012年第18期2487-2488,共2页 Journal of Qiqihar Medical University
关键词 三维适形放疗 非小细胞肺癌 吉西他滨(益非)顺铂 Three dimensional conformal radiotherapy Non-small-cell lung cancer
  • 相关文献

参考文献8

二级参考文献39

共引文献36

同被引文献38

  • 1张特,刘大海,王斌,李晓勇.恩度联合吉西他滨和顺铂二线方案治疗晚期非小细胞肺癌的近期疗效及安全性[J].中国全科医学,2009,12(11):969-971. 被引量:33
  • 2Ramalingam S,Belani CP.State of the art chemotherapy for advanced non-small cell lung cancer[J].Semin Oncol,2004,31(Suppl 1):68.
  • 3牛红蕊,寇小格,杨军.吉西他滨联合卡铂治疗晚期非小细胞肺癌近期临床观察[J].癌症进展杂志,2006,4(增刊):212-214.
  • 4Peters S, Adjei AA, Gridelli C, et al. Metastatic non small-ceil lung cancer (nscle) :Esmo clinical practice guidelines for diagnosis,treatment and follow-up[J]. Ann Oncol,2012,23(Suppl 7)56-64.
  • 5Gao G,Chu H,Zhao L,et al. A meta analysis of paclitaxel-based chemotherapies administered once every week compared with once every 3 weeks first-line treatment of advanced non small cell lung cancer[J]. Lung Cancer,2012,76(3)380-386.
  • 6Davidoff AJ, Tang M, Seal B, et al. Chemotherapy and survival benefit in elderly patients with advanced non small-cell lung cancer[J]. J Clin Oncoi,2010,28(13) .-2191-2197.
  • 7Quoix E,Monnet I,Scheid P,et al, management and outcome of french elderly patients with lung cancer: An ifct survey[J]. Rev Mal Respir,2010,27(5) :421-430.
  • 8Trigo Perez JM,Garrido Lopez P,Felip Font E,et al. Seom clini- cal guidelines for the treatment of non-small-cell lung cancer: An updated edition[J]. Clin Transl Oncol, 2010,12 ( 11 ) : 735-741.
  • 9Novello S,Besse B,Felip E,et al. A phase ii randomized study e valuating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small cell lung cancer[J]. Ann Oncol,2014,25(11) 2156-2162.
  • 10Califano R,Karamouzis MV,13anerjee S,et al. Use of adiuvant chemo therapy (ct) and radiotherapy (rt) in incompletely reseeted (rl) early stage non-small cell lung cancer (nsclc) :A european survey conducted by the european society for medical oneology (esmo) young oncolngists corrkmittee[J]. Lung Cancer,2014,85(1) :74 80.

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部